Patients treated with 5-mg midazolam nasal spray were more likely than those given placebo to remain seizure free for 6 hours after treatment or have their seizure terminated within 10 minutes, with ...
LOS ANGELES — The definition of seizure clusters varies significantly across epilepsy monitoring units (EMUs), according to a new survey of expert opinion. The findings should prompt the development ...
(BPT) - At just one day old, Spencer, born in Greenville, South Carolina, had his first seizure, a sudden, uncontrolled electrical disturbance in the brain that usually causes a change in behavior.
San Diego, California — It's still early days, but brand-new formulations of rescue benzodiazepine could be in store for patients who have acute repetitive seizures (ARS). Promising phase 3 trial ...
(RTTNews) - Aquestive Therapeutics, Inc. (AQST), a pharmaceutical company focused on delivering innovative medicines, announced that the FDA has granted Orphan Drug Exclusivity to Libervant (diazepam) ...
The Phase 3 open-label extension (OLE) study evaluated the safety of repeated, intermittent use of NAYZILAM in individuals living with epilepsy experiencing acute repetitive seizures, also known as ...
SAN DIEGO, Dec. 6, 2024 /PRNewswire/ -- Neurelis, Inc., today announced details of its presentations at the American Epilepsy Society (AES) Annual Meeting to be held December 6-10 in Los Angeles. The ...
SAN DIEGO, Dec. 6, 2024 /PRNewswire/ -- Neurelis, Inc., today announced details of its presentations at the American Epilepsy Society (AES) Annual Meeting to be held December 6-10 in Los Angeles. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback